Question

Match List I with List II
List I (Variety)
A. Pusa-3022
B. Pusa Double Zero
C. Pusa-12
D. Pusa-992
List II (Crop)
I. Mustard
II. Soybean
III. Pigeonpea
IV. Chickpea
Choose the correct answer from the options given below:

• A. A-I, B-II, C-III, D-IV
• B. A-IV, B-I, C-II, D-III
• C. A-IV, B-III, C-II, D-I
• D. A-III, B-I, C-II, D-IV

Hint:

"Double Zero" is a standard quality term for oilseed Mustard (indicating low erucic acid and glucosinolates). Knowing B-I allows you to quickly narrow down the options.

Answer 1

The Correct Option is B

Step 1: Understanding the Concept:
To prevent toxic compounds from entering the food chain and improve crop productivity, breeders develop specialized crop varieties.
These include low-toxin canola-type oilseed mustard and disease-resistant pulse varieties.
Identifying these varieties requires matching their official numerical designations to their respective crop species.

Step 2: Detailed Explanation:
Let us match each variety to its respective crop:
1. Pusa-3022 (A): This is a high-yielding, wilt-resistant kabuli chickpea (Cicer arietinum) variety developed by IARI, suitable for cultivation in irrigated areas.
Thus, A matches with IV.
2. Pusa Double Zero (B): The term "double zero" refers to canola-quality mustard (Brassica juncea) varieties that contain very low levels of erucic acid (less than 2%) in the oil and glucosinolates (less than 30 micromoles/g) in the defatted meal.
Pusa Double Zero Mustard 31 was the first such cultivar released in India.
Thus, B matches with I.
3. Pusa-12 (C): This is an improved, high-yielding, yellow-seeded variety of soybean (Glycine max) developed for cultivation in northern and central plains.
Thus, C matches with II.
4. Pusa-992 (D): This is an early-maturing, high-yielding variety of pigeonpea (Cajanus cajan) developed by IARI, suitable for double-cropping systems.
Thus, D matches with III.
Combining these matches: A-IV, B-I, C-II, D-III.
This matches Option 2.

Step 3: Final Answer
The correct matching is A-IV, B-I, C-II, D-III.